High ECM2 Expression Predicts Poor Clinical Outcome and Promotes the Proliferation, Migration, and Invasiveness of Glioma
Junsheng Li(National Clinical Research Center for Digestive Diseases), Wen Wang(University of Electronic Science and Technology of China), Chuming Tao(Capital Medical University), Yaowei Ding(Capital Medical University), Fa Lin(Capital Medical University), Wang Jia(Capital Medical University), Qiheng He(Capital Medical University), Siyu Wang(Zhengzhou University), Jizong Zhao(Capital Medical University)
Cited by 5
Related Papers
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
|Journal of Neurology|2020|132
RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3
|Journal of Clinical Investigation|2013|107
Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease
|Journal of neurosurgery|2018|105
Expression of Concern: Circadian gene Clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor‐suppressive miR‐124
|FEBS Letters|2013|90
RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance
|Journal of neurosurgery|2016|88